From: Survival of stroke patients after introduction of the ‘Dutch Transmural Protocol TIA/CVA’
Medication | Number of patients in Cohort 1 (%) | Number of patients in Cohort 2 (%) | ||||
---|---|---|---|---|---|---|
Before | After | p-value* | Before | After | p-value* | |
Antithrombotics | 50 (38.2) | 85 (64.9) | <0.001 | 56 (42.4) | 103 (78.0) | <0.001 |
Diuretics | 55 (33.6) | 36 (27.5) | 0.165 | 47 (35.6) | 49 (37.1) | 0.798 |
Beta-receptor blocker | 35 (26.7) | 46 (35.1) | 0.120 | 49 (37.1) | 48 (36.4) | 0.898 |
Calcium channel blocker | 14 (10.7) | 21 (16.0) | 0.116 | 18 (13.6) | 13 (9.8) | 0.339 |
Medication influencing renin-angiotensin system | 20 (15.3) | 30 (22.9) | 0.243 | 40 (30.3) | 58 (43.9) | 0.022 |
Antidiabetics | 20 (15.3) | 19 (14.5) | 0.964 | 24 (18.2) | 28 (21.2) | 0.536 |
Cholesterol-lowering medication | 15 (11.5) | 23 (17.6) | 0.035 | 39 (29.5) | 68 (51.5) | <0.001 |